JPMorgan raised the firm’s price target on CCC Intelligent Solutions (CCCS) to $14 from $13 and keeps an Overweight rating on the shares. The firm says vertical software-as-a-service companies ...
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback